{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"0","value":"0"},{"groupId":"OG001","lowerLimit":"30.1","upperLimit":"60.5","value":"42.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"64"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"378.1","upperLimit":"541.4","value":"452.4"},{"groupId":"OG001","lowerLimit":"757.5","upperLimit":"1258.1","value":"976.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"71"},{"groupId":"OG001","value":"56"}],"units":"Participants"}],"title":"Month 7"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"102.7","upperLimit":"169.8","value":"132.0"},{"groupId":"OG001","lowerLimit":"355.2","upperLimit":"686.1","value":"493.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"title":"Month 12"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"67.2","upperLimit":"119.4","value":"89.6"},{"groupId":"OG001","lowerLimit":"262.1","upperLimit":"531.6","value":"373.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"title":"Month 18"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"62.1","upperLimit":"114.9","value":"84.4"},{"groupId":"OG001","lowerLimit":"205.8","upperLimit":"438.1","value":"300.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"44"}],"units":"Participants"}],"title":"Month 24"}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"64"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 11 at each visit","dispersionType":"95% Confidence Interval","groups":[{"description":"Sero-negative for HPV 11 at baseline.","id":"OG000","title":"HPV 11 Sero-negative at Baseline"},{"description":"Sero-positive for HPV 11 at baseline","id":"OG001","title":"HPV 11 Sero-positive at Baseline"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"Baseline through month 24","title":"Geometric Mean Titers for HPV 11","type":"SECONDARY","unitOfMeasure":"mMU/mL"}